US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
What Happened in Niger?
Rare N.J. Earthquake Sends Shockwaves Along East Coast
Solar Eclipse April 8th, 2024